STOCK TITAN

Integra (IART) EVP awarded RSUs and stock options in new grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

INTEGRA LIFESCIENCES HOLDINGS CORP executive Michael J. McBreen, EVP & Chief Commercial Officer, received equity awards as part of his compensation. He was granted 31,909 restricted stock units and a non-qualified stock option for 60,372 shares at an exercise price of $15.67 per share. Both awards vest in three equal annual installments starting on the first anniversary of the grant date, contingent on his continued service. Following the RSU grant, he holds 124,017 shares of common stock directly.

Positive

  • None.

Negative

  • None.
Insider McBreen Michael J.
Role EVP & Chief Commercial Officer
Type Security Shares Price Value
Grant/Award Non-Qualified Stock Option (right to buy) 60,372 $0.00 --
Grant/Award Restricted Stock Units 31,909 $0.00 --
Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 60,372 shares (Direct, null); Restricted Stock Units — 124,017 shares (Direct, null)
Footnotes (1)
  1. This award consists of stock options granted pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan") and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, in each case subject to the Reporting Person's continued service through the applicable vesting dates. Grant of restricted stock units ("RSUs") pursuant to the Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
RSU grant 31,909 units Restricted Stock Units granted on June 1, 2026
Stock option grant 60,372 options Non-qualified stock options granted on June 1, 2026
Option exercise price $15.67 per share Conversion or exercise price for non-qualified stock options
Options expiration June 1, 2034 Expiration date for non-qualified stock options
Common shares after RSU grant 124,017 shares Direct common stock holdings following RSU award
Restricted Stock Units financial
"He was granted 31,909 restricted stock units and a non-qualified stock option"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Non-Qualified Stock Option financial
"a non-qualified stock option for 60,372 shares at an exercise price"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Equity Incentive Plan financial
"granted pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vesting financial
"Both awards vest in three equal annual installments starting on the first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
RSUs financial
"Grant of restricted stock units ("RSUs") pursuant to the Plan."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McBreen Michael J.

(Last)(First)(Middle)
1100 CAMPUS ROAD

(Street)
PRINCETON NEW JERSEY 08540

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy)$15.6706/01/2026A60,372 (1)06/01/2034Common Stock60,372$060,372D
Restricted Stock Units(2)06/01/2026A31,909 (3) (3)Common Stock31,909$0124,017D
Explanation of Responses:
1. This award consists of stock options granted pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan") and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, in each case subject to the Reporting Person's continued service through the applicable vesting dates.
2. Grant of restricted stock units ("RSUs") pursuant to the Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
3. All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
Remarks:
/s/ Michael D. Hutchinson; Attorney-in-Fact for Michael J. McBreen06/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Integra Lifesciences (IART) grant to Michael J. McBreen?

Michael J. McBreen received 31,909 restricted stock units and a non-qualified stock option for 60,372 shares. These compensation awards were granted under Integra’s Fifth Amended and Restated 2003 Equity Incentive Plan.

At what exercise price were Michael J. McBreen’s Integra (IART) stock options granted?

The non-qualified stock options were granted with an exercise price of $15.67 per share. This is the price at which he can purchase Integra common stock when the options become exercisable.

How do Michael J. McBreen’s restricted stock units at Integra (IART) vest?

The 31,909 restricted stock units vest in three equal annual installments. Vesting occurs on each of the first, second, and third anniversaries of the grant date, subject to his continued service with Integra Lifesciences.

What is the vesting schedule for Michael J. McBreen’s Integra (IART) stock options?

The 60,372 non-qualified stock options vest ratably in three equal annual installments. Each installment vests on the first, second, and third anniversaries of the grant date, conditioned on McBreen’s continued service.

When do Michael J. McBreen’s Integra (IART) stock options expire?

The granted non-qualified stock options expire on June 1, 2034. After this expiration date, any unexercised options will no longer be usable to purchase Integra Lifesciences common stock.

How many Integra (IART) common shares does Michael J. McBreen hold after this Form 4?

Following the restricted stock unit grant, Michael J. McBreen directly holds 124,017 shares of Integra Lifesciences common stock. This figure reflects his direct ownership position reported in the Form 4 filing.